UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

UnitedHealth Group (NYSE: UNH) provided updates on its 2025 annual shareholder meeting and actions taken by its Board of ...

UnitedHealth Group prepared talking points for its shareholder meeting this week. The company published them Wednesday after ...

UnitedHealthcare and Optum's struggles with an evolving Medicare Advantage market have investors questioning if valued-based ...

UnitedHealth Group (NYSE: UNH) will release its second quarter 2025 financial results on Tuesday, July 29, 2025, before the ...

A spokesperson for UnitedHealth Group said. "The Guardian refused to engage with the truth and chose instead to print its ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Stephen Hemsley previously served as CEO from 2006 through 2017 and has chaired the UnitedHealth Group board since 2017.

US insurance behemoth UnitedHealth Group is suing The Guardian for defamation weeks after the British-based newspaper ...

UnitedHealth said that Hemsley intends to stay on as CEO for at least three years. Its governance committee reviews and ...

With a price target of $377, analysts from the Bernstein SocGen Group reiterated their Outperform rating on UnitedHealth ...